As congenital heart disease (CHD) treatment advances, children with these conditions are living into adulthood, and over time, they may need additional treatment. A new expert consensus paper released today by the Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) provides guidance on transcatheter pulmonic valve replacement, or tPVR, for children and adults who were previously treated for CHD.
↧
CV organizations issue recommendations for minimally invasive valve treatments for children, adults
↧